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Application of the fluorescent contact sensitizer Rhodamin B 
on mouse epidermis was used to study the migration kinetics 
of Langerhans ce lls into the draining lymph nodes. The ex-
pression of the dendritic cell markers NLDC- 145 and 
M IDC-8 was followed over time to determine the correla-
tion between these markers and Langerhans cell migration. 
In contrast with its high expression on intraepidermal Lan-
gerhans cells, the expression ofNLDC-145 on dendritic cells 
in the draining lymph node was low at 24 h but increased at 
later times; in contrast, MIDC-8 expression on dendritic cells 
decreased. Ten days after Rhodamin B application, antigen-
bearing Langerhans cells were still present in the epidermis; 
application of another unrelated contact sensitizer to the epi-
dermis at this time did not lead to migration of these residual 
E pidermal Langerhans cells have been implicated as pivo-tal antigen-processing cells in the induction and expres-sion of contact sensitivity [1-4]. Following epicu-taneous exposure to a variety of sensitizing antigens, Langerhans cells are induced to migrate from the epi-
dermis, via the afferent lymphatics, to the regional lymph node. 
Here they can be identified within the population of interdigitating 
dendritic cells (DCs) [5 ,6], extremely potent antigen-presenting 
cells. This migration of antigen-bearing cells is consistent with the 
concept that the primary presentation of contact antigens to T cells 
occurs in the microenvironment of lymphoid organs. 
By using skin-sensitizing fluorochromes, such as fluorescein 
isothiocyanate (FITC) and Rhodamin B isothiocyanate (TRITC B), 
the uptake of antigen can be traced by fluorescence. With such an 
approach, dendritic cells in lymph nodes draining the skin contain-
ing Birbeck granules, characteristic of Langer hans cells and express-
ing fluoresceinated antigen, could be found [7]. Further confirma-
tion for this migration process has come from studies with 
allogeneic skin grafts, where dendritic cells of graft donor origin 
were found in draining lymph nodes [8]. 
Little is known about the regulation and kinetics of this migra-
tion process, although the influence of keratinocyte-derived cyto-
kines has been implicated [9] . Here we describe the kinetics and 
changes in phenotype of antigen-bearing Langerhans cells migrat-
ing from skin into draining lymph nodes of mice after skin painting 
with Rhodamin B. 
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Langerhans cells. These results indicate that not all antigen-
bearing Langerhans cells migrate from the skin after applica-
tion of a contact sensitizer, indicating that signals in addition 
to simple antigen binding are necessary for migration. Dur-
ing this migration from epidermis to lymph nodes Langer-
hans cells undergo phenotypic changes. The decreased ex-
pression of the endosomal antigens MIDC-8 and MOMA-2 
correlates with differentiation from predominantly antigen-
processing cells to predominantly antigen-presenting cells. 
The reduced expression ofNLDC-145 is discussed in light of 
a Langerhans cell-independent pathway of antigen transpor-
tation from skin to lymph node. Key words: dendritic cells/con-
tact sensitizer/antigen-bea ring cells/endosomal antigel1s. ] Irlvest 
DermatoI103:217-220, 1994 
MATERIA LS AND METHODS 
Animals Young adult (8 - 12 weeks, female) BALB/c mice were obtained 
from Harlan CPB (The Netherlands). 
Contact Sensitization Groups of mice were skin-painted with 2% Rho-
danUn B isothiocyanate (Sigma, St. Louis, MO) on the shaved abdomen, 
fore- and hindlimbs, and the dorsal skin of the ea.rs in a total volume of 50 Itl 
dimethylsulfoxide (DMSO) (Merck, Darmstadt, Gemlany)/acetone/dibu-
tyl phthalate (Sigma) 1 : 4.5: 4.5 or with 12.5% Rhodamin B in acetone/ 
DBF (1 : 1) . 
For the pulse-paint treatment, mice were pulsed with Rhodamin B on the 
outer rims of both ears. Using a barrier of vaseline, care was taken that only 
the outmost rims were painted. After 24 h the animals were anesthetized 
(Rompun/ Ascoket 3: 4) and the rhodaminated outer rims were carefully 
removed. At various timepoints after removal the animals were killed and 
their auricular lymph nodes draining the ears were analyzed. In some experi-
ments oxazolone (Sigma; 3% acetone/ethanol 1: 3) was app lied as a second 
antigen. 
Media and Reagents The culture medium used throughout was RPMI-
1640 (Gibco, Breda, the Netherlands) supplemented with 10% fetal bovine 
serum (FBS; Greiner, Alphen aid Rijn , the Netherlands), 2 mM glu tamine, 
100 U/ml penicillin, 100 J.Lg/ ml streptomycin, and 1 % Hepes (Flow Labo-
ratories, Irvine, U.K.) . 
Conditioned medium fro m GM10/]215 cells was used as a source of 
granulocyte/ macrophage colony-stimulating factor (GM-CSF) [10] . 
Isolation of Dendritic Cells Dendritic cells were isolated by the method 
described by Knight et al [5] , with modifications according to Vremec et al 
(11]. 
Briefly, draining lymph nodes of two mice were pooled, chopped into 
small fragments, then agitated in a collagenase IV (Sigma; 40 U/ mg, 0.5 
mg/ml)/DNAse I (Boehringer, Mannheim, Germany; 0.02 mg/ml) solu-
tion (RPMI/ Hepes/2% FBS) by rap idly pipetting up and down a wide-bore 
Pasteur pipette. The pieces were incubated for 30 seconds at 37°C, after 
which 0.1 M ethylenediaminetetraacetic acid (EDTA) was added (10%). 
The pieces were resuspended and incubated for another 5 min. The resulting 
cell suspension, which was obtained after enzyme treatment, was spun down 
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through 2 ml FBS/EDTA (1 ml 0.1 M EDTA + 10 ml FBS, incubated for 
30 sec). The pellet was resuspended in Hanks' balanced salt solution 
(HBSS)/FBS/EDTA (HBSS + Hepes, 0.2 mg/ml EDTA, 10% FBS/ 
EDTA) and pipetted through a wire mesh. Living cells were counted by 
trypan blue exclusion, and 5.10· cells/ml were layered onto 2 ml Nycodenz 
(Nycomed Pharma, Oslo, Norway) (14.5 gr/l00 ml HBSS/FBS/EDTA) 
and centrifuged for 20 min at 600 X g. Cells in the interface were collected, 
washed once, resuspended in HBSS/EDTA/l % bovine serum albumin 
(BSA), and examined. 
Epidermal Sheets Dorsal and ventral halves of split ears were floated in 
24-wells plates containing 10 mM EDTA (Merck) in HBSS without cal-
cium/magnesium (pH 7.3) for 2.5 hat 37"C. Epidermis was separated from 
the dermis with fine forceps under a dissection microscope. The sheets were 
washed for 10 min in HBSS containing calcium/magnesium (pH 7.3). 
Epidermal Cell Suspensions To prepare single-cel l suspensions epider-
mal sheets were incubated in dispase solution (Boehringer; 2 mg/ml) for 30 
min at 37'C, pushed through a wire mesh (100 lim), and washed, and the 
resulting cell suspension was pipetted again through a 50-lim wire mesh . 
Immunohistochemistry Cytospin preparations of the various cel l sus-
pensions and cultured cells were dried and fixed in pure acetone for 10 min. 
The cytospins were stained with the following rat anti-mouse monoclonal 
antibodies: M5/114 (major histocompatability complex [MHC] class II) 
(12), NLDC-145 (DC) [13), MOMA-2 (m<l>, LC) [14), F4/80 (m<l>, LC) 
[1 5), MlDC-8 (DC) (16), Thy-l (T-cells) [17), 187/1 (anti-kappa), MT4 
(CD4) (18), Lyt2 (CD8) [t 7), and the hamster anti-mouse monoclonal 
antibody N418 (DC) (19). These antibodies were visualized by a GoataRat-
FITC conjugate (Kirkegaard & Perry Lab. Inc., Gaithersburg, MD) or 
GoataHamster-FITC (Southern Bio Association, Birmingham, AL). 
The expression of the different markers on antigen-bearing cells was 
enumerated by the use of a fluorescent microscope with separate excitation 
filters for FITC and tetramethylrhodamine isothiocyanate (TRITC). Lan-
gerhans cells in epidermal sheets were stained with NLDC-145 and visual-
ized with GoataRat-FITC, followed by MHC class II staining using the 
biotinylated M5/114 monoclonal antibody in combination with avidin-
Texas-red (CALTAG; San Francisco, CAl . 
For enumeration of Langerhans ce lls in epidermal sheets the M5/114 
monoclonal antibody (anti-MHC class II) was visualized with RabbitaRat-
peroxidase (DAKO, Copenhagen, Denmark). An ocular wire grid of 
10 X 10 mm was used and 10 separate fields were enumerated for each ear. 
RESULTS 
The Effects of Rhoda min B Application on Langerhans Cells 
in the Epidermis To obtain additional insight into the kinetics 
of migration of antigen-bearing Langerhans cells and to describe 
their phenotypic characteristics, the fluorescent antigen Rhodamin 
B was applied to the skin of mice. At different timepoints after 
application, the density of Langerhans cells in the epidermal sheets 
was measured. The absolute number of Langerhans cells decreased 
rapidly in the first 16 h after antigen application and took at least 2 
weeks to return to control levels (Fig 1). This rapid decrease coin-
cided with the appearance of antigen-bearing cells in the draining 
lymph nodes. Rhodamin-bearing cells were observed in lymph 
node suspensions as early as 6 h after skin painting (data not shown), 
and a peak increase was seen at 24 - 48 h after application, after 
which the number of cells steadily decreased (Fig 2). 
What is the Phenotype of the Antigen-Bearing Cells? To 
confirm that the cells found in the draining lymph nodes indeed 
belonged to the Langerhans-dendritic cell lineage, lymph node sus-
pensions were purified by the metrizamide gradient method. The 
vast majority (> 99%) of antigen-bearing cells was found at the 
interface, consistent with the low buoyant density of dendritic cells. 
In addition, double labeling with a panel of monoclonal antibodies 
revealed that the antigen-bearing cells had a dendritic morphology, 
expressed high levels of MHC class II antigens, and did not express 
T -, B-cell or macrophage-specific markers (Table I). 
Surprisingly, at 24 h after skin painting the number of antigen-
bearing cells expressing NLDC-145 was low. This is in contrast to 
the situation in the epidermis, where there is a complete correlation 
between MHC class II and NLDC-145 expression. At later time-
points the proportion of antigen-bearing cells expressing NLDC-
145 increased. Furthermore, the expression of NLDC-145 cou ld be 
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Figure 1. Effect of Rhodamin B application on Langerhans cell density in 
epidermal sheets. At different timepoints after skin painting with Rhodamin 
B (1.25%) sheets were prepared and stained with anti-MHC class II. Using 
an ocular grid (10 X 10 mm) 10 random fields per sheet were counted and 
the number of Langerhans cells was determined. Each point represents the 
mean ± SD of three mice. 
upregulated in the presence of GM-CSF (Fig 3). The expression of 
the endosome-associated antigens MOMA-2 and MIDC-8 in the 
antigen-bearing cells decreased over time (Fig 3). 
The Kinetics of Migration The rapid drop in absolute numbers 
of Langerhans cells after skin painting (Fig 1) and the steady recov-
ery of this number in the epidermis clearly indicate a feedback 
mechanism starting very shortly after the induction of migration. 
Interestingly, when single-cell suspensions were made from epider-
mal sheets at various timepoillts after antigen application, Rhoda-
min B-Iabeled, MHC class II-positive, dendritic Langerhans cells 
could be found even at 10 d after antigen application, strongly 
suggesting that not all antigen-bearing Langerhans cells migrate 
from the epidermis after a single application of a contact sensi-
tizer. 
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Figure 2. Percentage of Rhodamin B-positive dendritic cells in purified 
lymph node suspensions. Animals were painted with Rhodamin B and at 
different timepoints draining lymph nodes were isolated and single-cell 
suspensions prepared. Dendritic cells were isolated on metrizamide and the 
percentage of antigen-bearing ce lls was determined. Bar, mean ± SO of 
three individual mice. Cells (100-200) were counted for each suspension. 
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Table I. Expression· of Different Markers on Rhodamin B-
Positive Cells in Lymph Node Suspensions 24 H 
Monoclonal Antibodies 
M5/114 
MOMA-2 
MIDC-8 
N418 
NLDC-145 
Thy-l 
MT4/ Lyt2 
187/1 
F4/80 
After Skin Painting" 
Marker 
MHC class II 
m<l>, LC 
DC 
DC 
DC 
T cells 
CD4/CD8 
B cells 
m<l>, LC 
Percentage of 
Positive Cells 
100 
79 ± 7.5 
78 ± 3.6 
32 ± 4.9 
25 ± 2.0 
o 
o 
o 
o 
• Rhodamin B was applied to the skin and 24 h later suspensions were prepared frol11 
rhe draining lymph nodes. Suspensions were purified on a Metrizamide gradient and 
cyrospins were counterstained with FITC~derecred antibodies. For each analysis with a 
given antibody, lymph nodes from two mice were pooled and three pam of nnce were 
compared. The data represent the mean (± SD) of three pairs. At least 100 cells were 
scored for each pair. 
To gain more insight into the possible regulatory mechanisms 
that govern this migration and retention, two approaches were fol-
lowed. First, we tested whether a second application to the epider-
mis of a chemically unrelated contact sensitizer could lead to 
migration of these residual antigen-bearing Langerhans cells. Ac-
cordingly, oxazolone was applied to the same skin sites to which 
Rhodamin B had originally been applied 10 d before. Twenty-four 
hours later the number of rhodaminated cells in the draining lymph 
nodes was examined (Fig 4). It was found that renewed stimulation 
did not lead to an increase of Rhodamin B-positive cells. In fact, a 
small reduction was observed, which may indicate a dilution of the 
Rhodamin-bearing dendritic cells in the lymph node by incoming 
Langerhans cell s bearing oxazolone but not Rhodamin B. 
For the second approach a "pulse-paint" method was utilized, 
which resulted in a discontinuous application of antigen on the 
epidermis (see Materials a/ld Methods). Removal of the epidermis 
24 h after Rhodamin painting led to a decrease of incoming Rhoda-
min-bearing cells in the draining lymph nodes (Fig 5). This indi-
cates that in spite of the massive efflux of Langerhans cells from the 
epidermis within the first 16 h, there sti ll is a considerable migra-
tion of antigen-bearing cells over the following days. 
DISCUSSION 
The rapid emigration of Langerhans cells from the epidermis and 
consecutive accumulat ion in the paracortical al·ea of the draining 
lymph nodes after antigen application has been demonstrated previ-
Figure 3. NLDC-145, MOMA-2, and 
MIDC-8 expression of Rhodamin B-
positive dendritic cel ls in lymph node 
suspensions at different timepoints after 
antigen application. Lymph node sus-
pensions of two mice were pooled; solid 
bars, means ± SO of three pairs. Ope/l 
bars, percentages of cells purified 1 d 
after skin painting and cu ltured for 48 h 
in the presence of GM-CSF. 
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ously in different systems [6,7,20] . The present studies have ex-
tended these observations by showing that not only is this migration 
strictly regul ated, but also that during migration the Langerhans 
cells undergo apparent phenotypic changes. These changes are con-
sistent with the conversion from a mainly antigen-processing to an 
antigen-presenting cell population once the cells have entered the 
micro-environment of the lymph node [21-23]. The decreased 
expression over time of MOMA-2 and MIDC-8 (see Fig 3) is con-
sistent with a loss of endosomal activity, because both MOMA-2 
and MIDC-8 antigens are situated in organelles of the endosomal-
lysosomal route [24]. Such a loss of endosomes, as well as Birbeck 
granules, has been demonstrated previously in cultured Langerhans 
cells [25]. 
Our data on the kinetics show that, in conformation with earlier 
findings of Macatonia et al [7], the process of emigration from the 
epidermis is very rapid. However, a substantial number of antigen-
bearing Langerhans cells could still be found in the epidermis as 
long as 10 d after initial antigen application. Furthermore, such 
cells were not easily induced to leave the skin after secondary anti-
gen application (Fig 4) . 
How is such emigration regulated? Most likely Langerhans cells 
migrate continuously from the epidermis, perhaps as part of their 
life cycle, or are actively induced by local stimuli in the skin. This 
process ensures a continuous immunologic surveillance of skin sites 
in the draining lymph nodes. A vigorous antigenic stimulus, as in 
our experiments, will then lead to a massive efflux of Langerhans 
cells. As seen in Figs 4 and 5, the emigration can last several days, but 
apparently involves only a part of the epidermal LC. The driving 
force ill both emigration and retention must be sought in the pro-
duction of specific cytokines. Such a role has been attributed to 
tumor necrosis factor (TNF)-a [9]. Interestingly, this cytokine, in 
combination with GM-CSF, has also been implicated in the matu-
ration of CD34+ hemopoietic precursors into Langerhans cells 
[26]. This way, the same stimulus may lead Langerhans cell to leave 
the skin and at the same time induce new precursors to differen-
tiate. 
The absence of the NLDC-145 antigen on many antigen-bearing 
dendritic cells ill the lymph node shortly after antigen application 
on the skin is in contrast with the complete correlation between 
MHC class II markers and this antigen on epidermal Langerhans 
cells, as originally described [13]. The exact function of the NLDC-
145 antigen is still unknown and one could argue that the emigra-
tion of Langerhans cells involves downregulation of its expression. 
However, this does not explain the substantial number of NLDC-
145+, antigen-bearing dendritic cells in the lymph node, nor the 
presence of N LDC-145+ veiled cells [13]. 
An alternative explanation is in keeping with recent proposals 
that state that dermal, MHC class II-positive macrophage/dendritic 
cells are involved in an additional, Langerhans cell-independent 
pathway of antigen transportation into the draining lymph nodes 
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Figure 4. Antigen-bearing cells in the drai11ing lymph nodes after restimu-
lation. Animals were skin painted with Rhodamin B. Ten days later the 
animals were painted with oxazolone (3% in acetone/ethanol) on the same 
skin sites. Twenty-four hours later the percentage of Rhodamin B-positive 
cells in the draining lymph nodes was determined. Hatched bars, percentage 
of cells from animals that were treated with Rhodamin B only. Opetl bar, 
animals that were treated on day 10 with the vehicle (acetone/ethanol) only; 
black bar, animals treated with oxazolone on the same skin sites that had been 
painted with Rhodamin 10 d previously. Bar, mean ± SD of three individual 
mice. Cells (50-100) were scored for each mouse. 
[27,28]. Our results suggest that the MHC class II+, NLDC-145-
cells may form an intermediate stage between precursor and epi-
dermal Langerhans cells and may eventually turn into lymphoid 
dendritic cells. The exact nature of the cells awaits further 
analysis. 
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Pigurc 5. Antigen-bearing cells in the draining lymph nodes after antigen 
pulse. Animals were skin painted with Rhodamin B on the outer rim of both 
ears by the use of a Vaseline barrier. Twenty-four hours later the outer rim 
was carefully (under anesthesia) removed in the pulse-group whereas the 
paint-group remained untouched. At different timepoints draining auricular 
lymph nodes were isolated and suspended. Lymph nodes of two mice were 
pooled. Dendritic cells were isolated on metrizamide and the percentage of 
antigen-bearing cells was determined. Black line, paint-group, dashed lillc, 
pulse group. Each timepoint is the mean ± SD of three pairs. 
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